Your browser doesn't support javascript.
loading
Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity.
Song, Anping; Ding, Tingting; Wei, Na; Yang, Jieren; Ma, Mingyue; Zheng, Shuguo; Jin, Huanhuan.
Afiliação
  • Song A; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
  • Ding T; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
  • Wei N; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
  • Yang J; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
  • Ma M; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China.
  • Zheng S; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China; Laboratory of Pharmacology of Chinese Medicine, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China. Electronic address: zhengsg2000@wnmc.edu.cn.
  • Jin H; Department of Pharmacology, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China; Laboratory of Pharmacology of Chinese Medicine, School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China. Electronic address: huanhuanjin@wnmc.edu.cn.
Toxicol Appl Pharmacol ; 472: 116574, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37271225
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lignanas / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lignanas / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China